еНаука - преглед
Преглед према Аутор Milosavljević, Filip
Приказ резултата 1 до 20 од 28
следеће >
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2022 | Association between CYP2C19 genotype and body weight with escitalopram exposure – a cross sectional study![]() | Jeremić, Aleksandra | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2024 | Association between escitalopram dose personalisation based on quantification of drug plasma levels and the outcome of escitalopram treatment![]() | Vuković, Petar G.; Jeremić, Aleksandra | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2021 | Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis![]() | Milosavljevic, Filip | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2024 | Current level of evidence for improvement of antidepressant efficacy andtolerability by pharmacogenomic-guided treatment: A Systematic reviewand meta-analysis of randomized controlled clinical trials![]() | Milosavljević, Filip | Научни чланак | 21aM21a - Водећи међународни часопис категорије M21a |
| 2025 | CYP2C19 in the developing brain of transgenic humanized knock-in mouse causes morphological changes in the cerebellum![]() | Atanasov, Andrea | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2022 | CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability![]() | Joković, Danilo; Milosavljević, Filip | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2022 | CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability: clinical study on 102 inpatients![]() | Joković, Danilo; Milosavljević, Filip | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2025 | Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study![]() | Vuković, Petar G. | Научни чланак | 21M21 - Водећи међународни часопис категорије M21 |
| 2022 | Effects of personalized dosing based on drug plasma level quantification on effectiveness and safety of escitalopram treatment![]() | Vuković, Petar | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2022 | Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids | Pridgeon, Chris; Bolhuis, Dian; Milosavljević, Filip | Article | 21M21 |
| 2022 | Humanized CYP2C19 transgenic mouse as an animal model of cerebellar ataxia![]() | Milosavljević, Filip | Conference Paper | Mp. category will be shown later |
| 2020 | Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis![]() | Milosavljević, Filip | Conference Paper | Mp. category will be shown later |
| 2024 | Living systematic review and meta-analysis of plasma-concentrations of antipsychotic drugs in carriers and non-carriers of variant CYP450 genotypes: Living systematic review protocol | Milosavljević, Filip | Article | 22M22 |
| 2020 | Long-Term Effects of Maternal Deprivation on the Volume of Dopaminergic Nuclei and Number of Dopaminergic Neurons in Substantia Nigra and Ventral Tegmental Area in Rats![]() | Kapor, Slobodan | Article | 21a+M21a+ |
| 2022 | Meta-analiza podataka o razlikama u izloženosti psihijatrijskim lekovima između sporih i normalnih CYP2C19/CYP2D6 metabolizera![]() | Milosavljević, Filip | Doctoral theses | 70M70 |
| 2017 | Obesity in relation with erythrocyte lead level in people exposed to environmental lead in Belgrade, Serbia | Baralić, Katarina | Conference Paper | Mp. category will be shown later |
| 2024 | Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-Analysis | Milosavljević, Filip | Article | 21a+M21a+ |
| 2022 | Pharmacogenomics in treatment of depression and psychosis: an update | Jukić, Marin | Article | 21a+M21a+ |
| 2019 | Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status | Milosavljević, Filip | Conference Paper | Mp. category will be shown later |
| 2019 | Quantification of antidepressant and antipsychotic exposure increase caused by CYP2C19 and CYP2D6 intermediate and poor metabolizer status by meta-analysis | Milosavljević, Filip | Conference Paper | Mp. category will be shown later |
